Pavlos Msaouel/X
Nov 2, 2024, 12:42
Pavlos Msaouel: How the observed adjuvant immunotherapy trial result discrepancies in kidney cancer
Pavlos Msaouel, Assistant Professor at MD Anderson Cancer Center, shared a post on X:
“Commentary European Urology led by Daniel Shapiro on how the observed adjuvant immunotherapy trial result discrepancies in kidney cancer can be explained by simple trial design principles.
Challenges and Considerations in Modern Adjuvant Therapy Trials in Renal Cell Carcinoma: A Call to Power
Authors: Daniel Shapiro, Pavlos Msaouel.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 3, 2025, 09:59
Sep 3, 2025, 09:57
Sep 3, 2025, 09:53
Sep 3, 2025, 09:50
Sep 3, 2025, 09:39